Difference in distribution functions: A new diffusion weighted imaging metric for estimating white matter integrity

Diffusion weighted imaging (DWI) is a widely recognized neuroimaging technique to evaluate the microstructure of brain white matter. The objective of this study is to establish an improved automated DWI marker for estimating white matter integrity and investigating ageing related cognitive decline. The concept of Wasserstein distance was introduced to help establish a new measure: difference in distribution functions (DDF), which captures the difference of reshaping one's mean diffusivity (MD) distribution to a reference MD distribution. This new DWI measure was developed using a population-based cohort (n=19,369) from the UK Biobank. Validation was conducted using the data drawn from two independent cohorts: the Sydney Memory and Ageing Study, a community-dwelling sample (n=402), and the Renji Cerebral Small Vessel Disease Cohort Study (RCCS), which consisted of cerebral small vessel disease (CSVD) patients (n=171) and cognitively normal controls (NC) (n=43). DDF was associated with age across all three samples and better explained the variance of changes than other established DWI measures, such as fractional anisotropy, mean diffusivity and peak width of skeletonized mean diffusivity (PSMD). Significant correlations between DDF and cognition were found in the UK Biobank cohort and the MAS cohort. Binary logistic analysis and receiver operator characteristic curve analysis of RCCS demonstrated that DDF had higher sensitivity in distinguishing CSVD patients from NC than the other DWI measures. To demonstrate the flexibility of DDF, we calculated regional DDF which also showed significant correlation with age and cognition. DDF can be used as a marker for monitoring the white matter microstructural changes and ageing related cognitive decline in the elderly.

[1]  Randy L. Gollub,et al.  Reproducibility of quantitative tractography methods applied to cerebral white matter , 2007, NeuroImage.

[2]  J. O'Brien,et al.  Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies , 2017, Clinical science.

[3]  Ian J Deary,et al.  Reliability and validity of the UK Biobank cognitive tests , 2019, PloS one.

[4]  P. Sachdev,et al.  An inverse relationship between serum macrophage inhibitory cytokine-1 levels and brain white matter integrity in community-dwelling older individuals , 2015, Psychoneuroendocrinology.

[5]  Qihao Guo,et al.  A Comparison Study of Mild Cognitive Impairment With 3 Memory Tests Among Chinese Individuals , 2009, Alzheimer disease and associated disorders.

[6]  D. Marchant,et al.  Risk factors. , 1994, Obstetrics and gynecology clinics of North America.

[7]  F. de Leeuw,et al.  A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms , 2016, Annals of neurology.

[8]  Cédric Villani,et al.  The Wasserstein distances , 2009 .

[9]  Edward G Lakatta,et al.  Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.

[10]  E. Gordon,et al.  Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study. , 2007, AJNR. American journal of neuroradiology.

[11]  R. Marioni,et al.  Brain age and other bodily ‘ages’: implications for neuropsychiatry , 2018, Molecular Psychiatry.

[12]  J. Whitwell,et al.  Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.

[13]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[14]  D. Peng,et al.  White matter integrity disruption in the pre‐dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment , 2019, European journal of neurology.

[15]  Zi-Gang Huang,et al.  Cognition-related white matter integrity dysfunction in Alzheimer's disease with diffusion tensor image , 2018, Brain Research Bulletin.

[16]  Haruyasu Yamada,et al.  Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis , 2002, Neurobiology of Aging.

[17]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[18]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[19]  J. Turner Inverse Relationship , 2020, Encyclopedia of Behavioral Medicine.

[20]  K. Lim,et al.  Advances in white matter imaging: A review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging , 2006, Neuroscience & Biobehavioral Reviews.

[21]  Perminder S. Sachdev,et al.  Microstructural White Matter Changes, Not Hippocampal Atrophy, Detect Early Amnestic Mild Cognitive Impairment , 2013, PloS one.

[22]  Daniel Levy,et al.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. , 2003, Circulation.

[23]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[24]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[25]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[26]  Stefan Klöppel,et al.  Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters , 2010, NeuroImage.

[27]  C. Lebel,et al.  Diffusion tensor imaging of white matter tract evolution over the lifespan , 2012, NeuroImage.

[28]  P. Sachdev,et al.  Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review , 2008, Current opinion in neurology.

[29]  Stuart J. Ritchie,et al.  Structural brain imaging correlates of general intelligence in UK Biobank , 2019, Intelligence.

[30]  Christopher Rorden,et al.  Image Processing and Quality Control for the first 10,000 Brain Imaging Datasets from UK Biobank , 2017 .

[31]  J. Broderick,et al.  Heart disease and stroke. , 1993, Heart disease and stroke : a journal for primary care physicians.

[32]  Michael J. Owen,et al.  Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects , 2017, Biological Psychiatry.

[33]  Tao Liu,et al.  UBO Detector – A cluster-based, fully automated pipeline for extracting white matter hyperintensities , 2018, NeuroImage.

[34]  Tony Wyss-Coray,et al.  Ageing, neurodegeneration and brain rejuvenation , 2016, Nature.

[35]  Stuart J. Ritchie,et al.  Brain age predicts mortality , 2017, Molecular Psychiatry.

[36]  J. Ridley Studies of Interference in Serial Verbal Reactions , 2001 .

[37]  P. Sachdev,et al.  Risk Factors for Late-Life Cognitive Decline and Variation with Age and Sex in the Sydney Memory and Ageing Study , 2013, PloS one.

[38]  C. Villani Topics in Optimal Transportation , 2003 .

[39]  L. Guarente,et al.  The brain, sirtuins, and ageing , 2017, Nature Reviews Neuroscience.

[40]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[41]  Jun Soo Kwon,et al.  Clinical and empirical applications of the Rey–Osterrieth Complex Figure Test , 2006, Nature Protocols.

[42]  L. Partridge,et al.  Facing up to the global challenges of ageing , 2018, Nature.

[43]  P. Matthews,et al.  Multimodal population brain imaging in the UK Biobank prospective epidemiological study , 2016, Nature Neuroscience.

[44]  Khader M. Hasan,et al.  Prediction of individual subject's age across the human lifespan using diffusion tensor imaging: A machine learning approach , 2013, NeuroImage.

[45]  Guo Qi Boston Naming Test in Chinese Elderly, Patient with Mild Cognitive Impairment and Alzheimer's Dementia , 2006 .

[46]  P. Sachdev,et al.  The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70–90 years , 2010, International Psychogeriatrics.

[47]  W. Chu,et al.  Peak width of skeletonized mean diffusivity and its association with age-related cognitive alterations and vascular risk factors , 2019, Alzheimer's & dementia.

[48]  R. Collins What makes UK Biobank special? , 2012, The Lancet.

[49]  Yan Zhou,et al.  Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease , 2019, NeuroImage: Clinical.